MiRagen’s cobomarsen misses skin treatment target in Phase II trial for lymphoma Tim October 6, 2020 BOULDER — One of the most prominent drug candidates in the MiRagen Therapeutics Inc. (Nasdaq: MGEN) pipeline failed to show […] Source: BizWest
BizWest celebrates 40 years covering business and recognizes 40 iconic leaders who inspired the region’s development. View related stories: Click here to view the 40th Anniversary supplement. ‘Turnpike’ helps define how economy has changed Wood: Preserving… Tim December 2, 2022
MiRagen says it has cash to last through late 2021 BOULDER — Cancer-drug developer MiRagen Therapeutics Inc. (Nasdaq: MGEN) posted a multi-million dollar loss in the last quarter but expects… Tim August 6, 2020
NoCo startup scores investment on Shark Tank LOVELAND — Another Colorado startup, this one from Loveland, has joined the pantheon of regional companies in the exclusive club… Tim December 4, 2022
Election 2022: Colorado decides Here are some of the ballot measures and elections that BizWest is tracking in Colorado, including measures in the Boulder… Tim November 9, 2022
OnKure aims for $60M in new funding round BOULDER — Biopharmaceutical company OnKure Inc. has raised nearly $54 million of a $60 million funding round, according to documents… Tim April 3, 2023